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Clustera b s t r a c t
Norovirus (NoV) is a major cause of epidemic gastroenteritis in industrialized countries, yet the epidemi-
ological signiﬁcance of NoV in industrializing countries remains poorly understood. The spatiotemporal
distribution of NoV genotypes identiﬁed in 2054 enrolled children was investigated between May 2009
and December 2010, in Ho Chi Minh City (HCMC), Vietnam. A total of 315 NoV extracted from stool sam-
ples were genotyped and GPS mapped to their source. Genogroup II NoV, particularly GII.4, were predom-
inant, and the GII.4 strains could be subgrouped into GII.4-2006b (Minerva) and GII.4-2010 (New
Orleans) variants. There was no spatiotemporal structure among the endemic GII strains; yet a signiﬁcant
spatiotemporal signal corresponding with the novel introduction of GII.4-2010 variant was detected.
These data show that NoV GII.4 variants are highly endemic in HCMC and describe a scenario of rapid
NoV strain replacement occurring in HCMC in early 2010.
 2013 The Authors. Published by Elsevier B.V. Open access under CC BY license.1. Introduction 2010); as a result, NoV frequently causes explosive gastroenteritisNorovirus (NoV) is a non-enveloped positive-sense single-
stranded RNA virus belonging to the taxonomic family Caliciviridae
(Green et al., 2000; Jiang et al., 1990). NoV accounts for a signiﬁ-
cant proportion of the global burden of viral gastroenteritis (Glass
et al., 2000, 2009; Patel et al., 2009, 2008), and up to 50% of all-
cause outbreaks of diarrhea (Patel et al., 2009). The disease
typically presents as acute watery diarrhea with vomiting and a
low-grade fever (Patel et al., 2009), and is usually self-limiting,
lasting between one and three days, but can be aggressive, severe
and protracted in young children, the elderly and the immuno-
compromised (Estes et al., 2006). NoV has an exceptionally low
infectious dose (10–100 viral particles (Patel et al., 2009)) and
can survive on surfaces for prolonged time periods (Weber et al.,epidemics (Estes et al., 2006; Patel et al., 2009, 2008).
The 7.5 kb genome of NoV has three open reading frames
(ORFs), encoding the RNase-dependent RNA polymerase (RdRp,
ORF1), the major capsid protein (VP1, ORF2) and the minor capsid
protein (VP2, ORF3) (Bertolotti-Ciarlet et al., 2003; Jiang et al.,
1993). The current classiﬁcation divides NoV into ﬁve genogroups
(GI – GV) on the basis of sequence identity within the major capsid
protein (VP1). Genogroups GI, GII and GIV are associated with
infections in humans (Zheng et al., 2006). Molecular characteriza-
tion of coding sequences within RdRp (region A and B) (Ando
et al., 1995, 2000; Fankhauser et al., 2002; Jiang et al., 1999; Vinje
and Koopmans, 1996) and ORF2 (region C, D and E) (Kageyama
et al., 2004; Kojima et al., 2002; Noel et al., 1997; Vinje et al.,
2004) is targeted for NoV detection, genogrouping and genotyping.
Genogroups I and II are the most common cause of human infec-
tions (Donaldson et al., 2010), and can be differentiated into 8 GI
and 23 GII capsid genotypes, and 14 GI and 29 GII polymerase
genotypes (Kroneman et al., 2011; Zheng et al., 2006).
The epidemiology of NoV is complex and is inﬂuenced by a
multitude of factors, including population immunity, the environ-
ment, and seasonality (Donaldson et al., 2010; Marshall and
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acknowledged interpretation of global NoV epidemiology, particu-
larly GII.4 genotype, is that strain replacement occurs every two to
three years (Bull et al., 2010; Bull and White, 2011; CDC, 2010;
Donaldson et al., 2008; Siebenga et al., 2009). Over the last two
decades, these replacements were typically caused by strains of a
single lineage of a GII.4 genotype, which have been responsible
for the majority of NoV outbreaks worldwide since being ﬁrst iden-
tiﬁed in the USA in the mid 1990s (Bull and White, 2011; Noel
et al., 1999). At least four major global NoV replacements have
been described since 1995, each due to a novel GII.4 variant (Bull
et al., 2006; Noel et al., 1999; Siebenga et al., 2010; Tu et al.,
2008), believed to have escaped immunity in the population
through antigenic variation (Lindesmith et al., 2012b, 2012c, 2011).
The majority of NoV studies are performed in industrialized
countries and disease outbreaks are continually monitored
through several disease surveillance networks (Vega et al., 2011;
Verhoef et al., 2009). However, little is known about the transmis-
sion, molecular diversity or spatiotemporal dynamics of NoV infec-
tions in areas with differing public health infrastructure and
demographics. Vietnam is an industrializing country with densely
populated urban centers and a changing spectrum of infectious
diseases as a presumed consequence of rapid economic develop-
ment and urbanization (Vinh et al., 2009). NoV was ﬁrst reported
in Ho Chi Minh City (HCMC) in 1999 (Hansman et al., 2004), and
our recent work has demonstrated that NoV is endemic throughout
the year, in contrast to the winter outbreaks observed in temperate
locations (Lopman et al., 2009; Mounts et al., 2000). To understand
the epidemiology and NoV strain diversity in HCMC, we investi-
gated the molecular and spatiotemporal distribution of NoV geno-
types in young hospitalized children between May 2009 and
December 2010 in HCMC, Vietnam.
2. Material and methods
2.1. Study setting and design
This study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the ethical re-
view boards of Children’s Hospital 1 (HCMC), Children’s Hospital 2
(HCMC), the Hospital for Tropical Diseases (HCMC), and the Oxford
Tropical Research Ethics Committee (OxTREC Approval No. 0109)
(Oxford). The parents or legal guardians of the enrolled children
were required to provide written informed consent for sample col-
lection and residential mapping.
A stool specimen was collected within 24 h of enrollment from
each recruited individual (1443 diarrheal patients and 611 asymp-
tomatic controls). These participants (N = 2054) were children of
0–60 months of age and residents of HCMC, Vietnam, over the
study period from May 2009 to December 2010. Diarrheal patients
were children with acute diarrheal disease (P3 loose stools or at
least one bloody loose stool within 24 h period (WHO, 2005))
who were admitted to the three study sites and had not received
treatment with antimicrobials in the three days prior to hospital
admission. Asymptomatic controls were diarrhea-free children
attending Children’s Hospital 1 or Children’s Hospital 2 for nutri-
tional health checks or for other gastrointestinal issues unrelated
to diarrhea or gastroenteritis without any history of diarrhea,
respiratory illness or treatment with antimicrobials within 7 days
of study enrollment.
2.2. Norovirus detection
Total viral RNA was extracted and reverse transcribed into
cDNA as previously described (Tra My et al., 2011). Norovirus
genogroup I (GI) and II (GII) were detected in separate reactionsby conventional Reverse Transcriptase Polymerase Chain Reaction
(RT PCR) using consensus primers, G1SKF/G1SKR (Kojima et al.,
2002) and COG2F/G2SKR (Kageyama et al., 2003; Kojima et al.,
2002) for GI and GII, respectively. These PCR primers amplify a re-
gion between position 5342 and 5671 (330 bp) in the genome of
NoV GI (Norwalk/68, GenBank accession No. M87661) containing
an overlap of 17 bp of 30 end ORF1 and 313 bp of 50 end ORF2,
and between position 5003 and 5389 (387 bp) in the genome of
NoV GII (Lordsdale/93, GenBank accession No. X86557) containing
an overlap of 83 bp of 30 end ORF1 and 304 bp of 50 end ORF2.
2.3. Norovirus genotyping
NoV positive PCR amplicons were puriﬁed using the QIAquick
PCR puriﬁcation kit (QIAGEN, Hilden, Germany), and subjected to
direct sequencing using the ampliﬁcation primers. DNA concentra-
tions were determined using a NanoDrop ND-1000 spectropho-
tometer (Thermo Fisher Scientiﬁc, United Kingdom) and direct
sequencing was performed using a BigDye Terminator Cycle
Sequencing kit (Applied Biosystems, USA) and generated with an
ABI Prism 3130xl Genetic Analyzer (Applied Biosystems, USA).
DNA sequences were assembled using DNA Baser Sequence Assem-
bler v3.0.17 (Heracle Biosoft, Pitesti, Romania). NoV genotypes
were assigned based on ORF2 sequences using the online Norovi-
rus Automated Genotyping Tool, as directed (Kroneman et al.,
2011).
2.4. Construction of NoV phylogenies
DNA sequences were uploaded into GenBank (HE716437 to
HE716751) and used for local phylogenetic construction. Manual
alignment of all sequences was performed in Se-AL (http://tree.-
bio.ed.ac.uk/software/ﬁgtree/) prior to phylogenetic reconstruc-
tion. Maximum likelihood (ML) trees were inferred using RAxML
(Stamatakis et al., 2008), employing the general-time reversible
model of nucleotide substitution with a gamma distribution of
among-site rate variation (GTR +C) and 1000 bootstrap replicates.
Resulting trees were visualized in FigTree v1.3.1 (http://tree.bio.e-
d.ac.uk/software/ﬁgtree/) and mean pairwise genetic distances
were estimated in MEGA 5 (Tamura et al., 2011).
Two hundred and sixty-nine global GII.4 strains encompassing
the global diversity of GII.4 variants were retrieved from GenBank
(http://www.ncbi.nlm.nih.gov/); 43 of these strains originated
from previous studies conducted in Vietnam (Hansman et al.,
2004; Nguyen et al., 2008, 2007a, 2007b; Tamura et al., 2010;
Trang et al., 2012). In addition, available archived samples that
were Enzyme-Immuno Assay (EIA) positive for NoV (GI and GII)
from our previous work in 2008 from southern Vietnam (Tra My
et al., 2011) were also selected for analysis and genotyped using
the same methodology.
The time of isolation for each of the NoV strains was retrieved
from GenBank or the publication associated with the sequence,
and the year of isolation was used to calculate evolutionary rate.
All sequences were aligned in Se-AL and trimmed to 378 bp to cor-
respond with the sequences identiﬁed in this study to maximize
sequence homology for phylogenetic reconstruction. Phylogenetic
reconstructions of relationships among the GII.4 variants identiﬁed
in this study and global GII.4 sequences were inferred using the
Bayesian Markov chain Monte Carlo (MCMC) method as imple-
mented in BEAST (Drummond and Rambaut, 2007). A GTR substi-
tution model with gamma-distributed rate variation and a
relaxed uncorrelated lognormal clock model with a constant pop-
ulation size were employed. The MCMC analysis was run for 50
million generations (with a burn-in of 5 million) and analyzed
using Tracer (http://tree.bio.ed.ac.uk/software/tracer/) to ensure
that all parameters had converged. Maximum clade credibility
Table 1
The distribution of NoV genogroups and geno-
types identiﬁed in enrollees over the sample
collection period in HCMC, Vietnam.
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alized in FigTree v1.3.1. The weighted average evolutionary rates












II.6 8 (2.5)2.5. Mapping of corresponding residential addresses
The location of each enrollee’s residence was recorded using an
eTrex Legend GPS device (Garmin, United Kingdom) and veriﬁed by
an additional member of the study team. Latitude and longitude of
each residence (recorded in decimal degrees) were entered along
with patient metadata in Microsoft Excel (Microsoft, Redmond,
USA). Location data were converted to KML format and locations
were visualized and validated in Google Earth version 5 (http://




Total 3152.6. Spatiotemporal analyses
Mantel tests were performed to assess potential correlations
between genetic, temporal, and spatial distances of GII strains
and variants within the GII.4 clade, using the ade4 package in R
(R_Development_Core_Team, 2011) (ww.ats.ucla.edu/stat/r/faq/
mantal_test.htm). A Bernoulli model was used to examine spatio-
temporal clusters of GII.4-2010, using all non-GII.4-2010 to repre-
sent the background distribution of the NoV population using
SaTScan v9.1.1 software (http://www.satscan.org/). For the current
analysis, the upper limit for cluster detection was speciﬁed as 10%
of the study population over 10% of the study duration. The signif-
icance of the detected clusters was assessed by a likelihood ratio
test, with a p-value obtained by 999 Monte Carlo simulations gen-
erated under the null hypothesis of a random spatiotemporal
distribution.3. Results
3.1. The temporal distribution of NoV genogroups and genotypes
Over the period of study, 315 NoV positive stool samples from
2054 individuals were identiﬁed (15.3%). Genotyping of these
315 strains demonstrated that the predominant NoV genogroup
was GII (304; 96.5%), with NoV GI identiﬁed in only 3.5% of enrol-
lees (Table 1). An array of GI (GI.3, GI.4 and GI.5) and GII (GII.2,
GII.3, GII.4, GII.6, GII.7, GII.9, GII.12, GII.13 and GII.4U (genotype 4
with unassigned variants, outgroup of the lineage containing
strains OB200615 and X76716 according to RIVM-NoroNet)) geno-
types were additionally detected. Among the 304 NoV GII strains,
GII.4 was the most frequently identiﬁed (247; 81.3%) and could
be separated into two major variants, GII.4-2006b (Minerva)
(86.2%; 213/247) and GII.4-2010 (New Orleans) (12.1%; 30/247).
The GII.4-2006b and GII.4-2010 variants were the focus of subse-
quent analyses as a consequence of their overall dominance and
their perceived epidemiological relevance in HCMC.
The genotyping data were combined with isolation dates to
illustrate the distribution of GII.4 variants over the period of sam-
ple collection (Fig. 1). NoV GII.4 strains were detected every month
from May 2009 to April 2010, with GII.4-2006b being the sole GII.4
variant identiﬁed between May and November 2009. However, this
trend was not uniform as there was a substantial increase in GII.4-
2006b infections during September and October 2009. The GII.4-
2010 variant was ﬁrst detected in December 2009 and became
increasingly prevalent in the following months. Concurrently, the
proportion of GII.4-2006b variants decreased from 7.36% (17/
231) in December 2009 to 1.73% (4/231) in February 2010, and
was not detected after March 2010. However, trends in the distri-
bution of NoV variants were difﬁcult to assess during the periodafter April 2010 due to the limited number of enrollees recruited
in this period.3.2. Phylogenetic analyses of NoV sequences
Phylogenetic analyses were performed on all GI and GII NoV se-
quences, and the mean uncorrected genetic distances among the
strains within the GII and between variants within the GII.4 geno-
type (pairwise distance of maximum composite likelihood calcula-
tion) were 0.147 and 0.016 substitutions/site, respectively. Based
on this primary phylogenetic analysis, the GI strains were excluded
and the GII strains were subsampled by removing identical GII se-
quences to reconstruct a maximum likelihood phylogenetic tree
summarizing the genetic diversity present in HCMC (N = 109)
(Fig. 2).
Sequences of the two GII.4 variants from HCMC (N = 247) were
compared with 269 global sequences and 10 selected GII.4
sequences isolated in 2008 in southern Vietnam (Tra My et al.,
2011) (Fig. 3). Using the Bayesian MCMC method and time-
stamped sequences, the evolutionary rate of NoV GII.4 was
estimated to be 8.072  103 substitutions/site/year (95% Highest
Probability Density (HPD): 6.195  103, 1.012  102). The
GII.4-2006b sequences from NoV originating in Vietnam fell in
the same clade as global GII.4-2006b viruses, with clustering unre-
lated to the time or place of isolation. This GII.4-2006b lineage
could be further divided into two sub-lineages; strains from HCMC
could be found in both, conﬁrming co-circulation of divergent
GII.4-2006b viruses. Notably, the upper sub-lineage contained
more sequences from this study while more Vietnamese strains
from previous studies fell in the lower sub-lineage. The GII.4-
2010 strains clustered in a single lineage, separate from the
GII.4-2006b lineage. The GII.4-2010 lineage could be differentiated
partially by location, with Vietnamese and Belgian sub-lineages
stemming from the New Orleans GII.4-2010 variant.3.3. Spatiotemporal clustering of NoV in HCMC
The temporal data suggested that a NoV strain replacement oc-
curred during the period of investigation. There was a signiﬁcant
association between the genetic distance of strains within GII
and their date of isolation (p < 0.0001; Mantel test), this association
was particularly apparent between the GII.4 sequences and their
isolation date (p < 0.0001; Mantel test). However, there was no
similar association between geographical distance and genetic dis-
tance (p = 0.197 for GII strains; p = 0.844 for GII.4 sequences), or
Fig. 1. The temporal distribution of NoV GII.4 variants in HCMC over the period of study, from May 2009 to December 2010. Graph showing the distribution of GII.4-2006b
and GII.4-2010 variants against other NoV strains (total numbers identiﬁed) detected in symptomatic and asymptomatic children over the study period (GenBank accession
number HE716437 to HE716751).
338 P.V. Tra My et al. / Infection, Genetics and Evolution 18 (2013) 335–343between isolation date and geographical distance (p = 0.248 for GII
strains; p = 0.851 for GII.4 sequences). These data indicate a lack of
a local transmission signal of NoV in HCMC. Yet, a spatiotemporal
cluster detection analysis performed in SaTScan supported our ori-
ginal hypothesis, detecting a cluster of six GII.4-2010 NoV (over
other NoV GIIs (0.59 expected)) in a 3.8 km radius in the northeast
of the City (relative risk = 12.65, p = 0.0003) (Fig. 4), indicating that
the initial dynamics of GII.4-2010 were highly localized during
their introduction period into HCMC.
4. Discussion
There are inadequate data regarding the burden of NoV disease
in industrializing countries such as Vietnam; this limits our knowl-
edge of viral distribution, transmission chains and local microevo-
lution. Data on NoV genotype distribution across a range of
geographical locations through time is essential for understanding
global NoV epidemiology. This is particularly important with re-
spect to the ongoing development and clinical trials of NoV vac-
cines (Atmar et al., 2011; El-Kamary et al., 2010; Parra et al.,
2012), which should be developed in consideration of global and
regional strain circulation and their ability to induce cross-protec-
tion. Here, by examining the genetic, spatial and temporal dynam-
ics of NoV in children in HCMC, we aimed to assess the local
molecular epidemiology of NoV. Our data show a diverse array of
NoV genotypes and the emergence of a novel variant. The emer-
gence of the GII.4-2010 and subsequent lack of GII.4-2006b isolates
suggest that a rapid strain replacement event may have occurred in
the population, although the small numbers of isolates from the
latter half of the study preclude strong inference on these
dynamics.
Strains belonging to GII are responsible for the vast proportion
of human NoV infections worldwide, and GII.4 variants play a par-
ticularly important role in pediatric NoV infections (Bull and
White, 2011; Lopman et al., 2004; Siebenga et al., 2009). Here, a
variety of NoV GII genotypes were found to be co-circulating, withGII.4 predominating. This observation is consistent with work orig-
inating in northern Vietnam (Trang et al., 2012) and other locations
across Asia (Zeng et al., 2012), and we conﬁrm that GII.4-2006b has
continued to circulate in southern Vietnam since it was ﬁrst de-
tected in 2005 (Nguyen et al., 2008).
The GII.4-2010 variant detected here in December 2009, and
ﬁrst identiﬁed in October 2009 in New Orleans (USA) (Vega et al.,
2011), was also reported in Belgium (Mathijs et al., 2011) and then
internationally (Greening et al., 2012; McAllister et al., 2012; Ngu-
yen and Middaugh, 2012; Puustinen et al., 2011; White et al.,
2012), suggesting that this variant is the ﬁrst globally disseminated
strain to emerge since the pandemic GII.4-2006b (Minerva). The
phylogenetic analyses demonstrated that the GII.4-2010 strains
from the USA, Belgium and Vietnam were closely related, suggest-
ing that these strains may have been introduced into Vietnam from
the USA or Europe in 2009. Furthermore, the substitution rate for
GII.4 (8.072  103 substitutions/site/year) estimated here is high-
er than previously reported (between 3.9  103 and to 5.3  103
substitutions/site/year) (Bok et al., 2009; Bull et al., 2010; Siebenga
et al., 2010). This new estimate might reﬂect an increase in the rate
of GII.4 evolution involving GII.4-2010 viruses, since Bok et al.
(2009), Bull et al. (2010) and Siebenga et al. (2010) would have
used a different sequence dataset (i.e. no GII.4-2010 sequences)
given that their work was conducted prior to the emergence of
GII.4-2010 (Bok et al., 2009; Bull et al., 2010; Siebenga et al.,
2010). However, it is important to note that differences in the
region of sequence selected for analysis (partial 50 capsid herein
versus complete capsid in previous studies), in addition to the dif-
ferential method of evolutionary inference (linear regression,
strict or relaxed clock, uncorrelated lognormal or exponential
model) or the measured unit of time, do not enable an accurate
evolutionary comparison between studies. Nevertheless, the phe-
nomenon observed in this study certainly warrants further
investigation.
A spatiotemporal signal for GII.4-2010 was detected for several
months after it was introduced into HCMC but there was no similar
Fig. 2. Phylogenetic tree of 109 NoV GII strains from HCMC. Tree constructed from 109 NoV GII strains collected during this study and based on the GII ampliﬁcation fragment
trimmed to 378 bp. All horizontal branch lengths are drawn to the scale of a nucleotide substitution per site. Tree is mid-point rooted with branches according to viral
genotypes/variants. Strains from asymptomatic individuals are labeled with a circle. Only bootstrap values of >75 are shown.
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tial explanation for the absence (GII.4-2006b and non-GII.4) and
presence (GII.4-2010) of spatial signals in the NoV sequences is
that GII.4-2006b and non-GII.4 genotypes were in a state of equi-
librium when GII.4-2010 was introduced, and the GII.4-2010
exhibited an outbreak dynamic and exponential growth upon
introduction. Similar replacement of GII.4-2006b viruses following
the introduction of GII.4-2010 has been observed in Belgium
(Mathijs et al., 2011), and NoV strain replacement has been ob-
served in various NoV pandemics. These replacements include,GII.4-1997 (USA 95/96 variant), -2002 (Farmington Hills variant),
-2004 (Hunter variant), -2006 comprising of GII.4-2006a (Laurens
variant) and the -2006b (Minerva variant) (Bull and White, 2011;
Donaldson et al., 2008; Lindesmith et al., 2011). Novel pandemic
NoV GII.4 strains emerge every two to three years and it appears
that novel GII.4 genotypes are capable of replacing existing GII.4
variants but not other endemic strains (such as GII.3, GII.6, GII.2)
(Bull et al., 2010; Bull and White, 2011; CDC, 2010; Donaldson
et al., 2008; Lindesmith et al., 2011; Siebenga et al., 2009). How-
ever, there is no current consensus on the underlying mechanism
Fig. 3. Phylogenetic tree of GII.4 NoV strains from HCMC and globally representative sequences. Maximum likelihood phylogenetic tree of 526 global and HCMC GII.4 NoV
strains constructed from the ampliﬁcation region trimmed to 378 bp. All horizontal branch lengths are drawn to the scale of a nucleotide substitution per site per year. Branch
tips are colored according to the viral genotype and color-coded by their continent of isolation. Vietnamese strains included are from this study (N = 247), other studies
(‘‘other’’; N = 43) and from a 2008 study in southern Vietnam (N = 10) (Tra My et al., 2011) denoted by (⁄). The GII.4-2010 clade is magniﬁed to highlight the strains
originating from Vietnam, Belgium and America.
340 P.V. Tra My et al. / Infection, Genetics and Evolution 18 (2013) 335–343of GII.4 strain emergence and replacement, but may be induced by
antigenic drift and herd immunity escape (Debbink et al., 2012;
Donaldson et al., 2010; Lindesmith et al., 2012a, 2012c). Recent
studies on mapping blockade epitopes in GII.4 VLPs (virus-like
particles) have provided evidence that variation in the major
neutralizing epitopes facilitate evasion of herd immunity against
GII.4-2006b (Minerva), thus facilitating the emergence of GII.4-
2010 (New Orleans) (Lindesmith et al., 2012b, 2012c, 2011).Our study has some limitations; including not tracking the
source and/or route of transmission or examining the genotype
distribution after the period of investigation. Therefore, it is difﬁ-
cult to determine if the shift in the distribution of the GII.4 variants
over time is due to an emergent virus becoming ﬁxed in the pop-
ulation, or a local outbreak in the northeast of the city. The short
temporal investigation also limits the determination of the magni-
tude to which the local NoV dynamics observed in HCMC reﬂect or
Fig. 4. The spatiotemporal clustering of NoV GII.4-2010 strains. When compared to all other GII strains, GII.4-2010 strains were found to cluster in the northeast of Ho Chi
Minh City during March–April 2010. This signiﬁcant cluster with radius 3.8 km, shown by the black circle, contained 6 GII.4-2010 NoV (0.59 expected, relative risk = 12.65,
p = 0.0003). Orange dots represent NoV GII.4-2010 strains located within the cluster, blue dots represent the non-GII.4-2010 NoV within the radius of the cluster, and the
green dots represent all other NoV strains (GII.4-2010 and non-GII.4-2010) found over the study period that were not found to cluster. The yellow square indicates the
location of the Hospital for Tropical Diseases, the star indicates Children’s Hospital 1 and the triangle indicates Children’s Hospital 2. The thin black lines represent district
boundaries within Ho Chi Minh City.
P.V. Tra My et al. / Infection, Genetics and Evolution 18 (2013) 335–343 341follow the global evolutionary trend, such that we are unable to
determine whether GII.4-2010 viruses continued circulating with-
in this setting after the study period or were capable of diffusing
across the country in the presence or absence of GII.4-2006b
viruses. The status of population-level immunity to NoV in the
population of HCMC is unknown, so we are unsure if exposure to
GII.4-2006b NoV is protective against the -2010 variants. These
ﬁndings highlight a broader scientiﬁc issue concerning outstanding
questions on immune cross-protection in the space of NoV variants
(Lindesmith et al., 2012c, 2011). Furthermore, the analysis was not
performed on whole genome sequences and focused on a fragment
of the genome, which may restrict the phylogenetic interpretation.
Whole genome sequencing would greatly improve the utility of
NoV epidemiological datasets, speciﬁcally to study the evolution
of novel GII.4-2010 variants, aiding the detection of genomic sites
that may induce potential antigenic variation. Finally, our hospital-
based study design may be inﬂuenced by healthcare-seeking
behavior, and may not be representative of the NoV in the local
community.5. Conclusions
This study expands the knowledge of NoV in industrializing
countries, outlining a range of endemic NoV genotypes over a
one-year period in HCMC. The analysis describes the co-circulation
of heterogeneous NoV strains, and reports the identiﬁcation ofGII.4-2010 (New Orleans) in Asia, resulting in the replacement of
a GII.4-2006b variant by the emergent GII.4-2010 strain. In conclu-
sion, during the period of study, NoV GII-4 infections in HCMC
demonstrated a spatiotemporal phylogenetic relationship, driven
by the emergence of the GII.4-2010 (New Orleans) variant.
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